Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 2 Terminated 1 Suspended 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Oxaliplatin 197 Bevacizumab 161 Fluorouracil 154 Capecitabine 137 Gemcitabine 134 Leucovorin 111 pembrolizumab 99 Cisplatin 94 Drug Therapy 89 Irinotecan 80 Radiotherapy 73 sintilimab 70 130-nm albumin-bound paclitaxel 66 durvalumab 65 Paclitaxel 64 Specimen Handling 62 Cetuximab 61 lenvatinib 59 tislelizumab 58 Nivolumab 55 Magnetic Resonance Spectroscopy 55 Folfox protocol 55 Blood Specimen Collection 52 atezolizumab 47 Biopsy 46 Surgical Procedures, Operative 40 Taxes 39 Albumin-Bound Paclitaxel 39 Immune Checkpoint Inhibitors 37 HMPL-013 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × poly(I).poly(c12,U) × Gastrointestinal × Clear all

NCT05927142 2025-02-25

DURIPANC

Erasmus Medical Center

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡